PADHI IAN DESMOND,JANG GRAHAM RICHARD,PADHI Ian Desmond,JANG Graham Richard
申请号：
SI200831170
公开号：
SI2195026T1
申请日:
2008.09.17
申请国别(地区):
SI
年份:
2014
代理人:
摘要：
The invention is directed to a method of inhibiting bone resorption. The method comprises administering to a human an amount of sclerostin inhibitor that reduces a bone resorption marker level for at least 2 weeks. The invention also provides a method of monitoring anti-sclerostin therapy comprising measuring one or more bone resorption marker levels, administering a sclerostin binding agent, then measuring the bone resorption marker levels. Also provided is a method of increasing bone mineral density； a method of ameliorating the effects of an osteoclast-related disorder； a method of treating a bone-related disorder by maintaining bone density； and a method of treating a bone-related disorder in a human suffering from or at risk of hypocalcemia or hypercalcemia, a human in which treatment with a parathyroid hormone or analog thereof is contraindicated, or a human in which treatment with a bisphosphonate is contraindicated.
